EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $168 | -65.7% | 10,622 | -57.8% | 0.00% | – |
| Q2 2023 | $490 | +210.1% | 25,170 | +351.9% | 0.00% | – |
| Q1 2023 | $158 | -84.3% | 5,570 | -83.8% | 0.00% | – |
| Q4 2022 | $1,005 | -99.9% | 34,395 | -11.4% | 0.00% | -100.0% |
| Q3 2022 | $1,026,000 | +570.6% | 38,813 | +1028.3% | 0.00% | – |
| Q2 2022 | $153,000 | -66.4% | 3,440 | -62.5% | 0.00% | – |
| Q1 2022 | $455,000 | -70.0% | 9,178 | -69.3% | 0.00% | – |
| Q4 2021 | $1,518,000 | +131.1% | 29,852 | +153.5% | 0.00% | – |
| Q3 2021 | $657,000 | +140.7% | 11,777 | +84.9% | 0.00% | – |
| Q2 2021 | $273,000 | -72.6% | 6,370 | -73.4% | 0.00% | -100.0% |
| Q1 2021 | $998,000 | -16.1% | 23,927 | -6.3% | 0.00% | 0.0% |
| Q4 2020 | $1,189,000 | -1.2% | 25,532 | -10.0% | 0.00% | 0.0% |
| Q3 2020 | $1,203,000 | +82.5% | 28,360 | +106.3% | 0.00% | 0.0% |
| Q2 2020 | $659,000 | -62.4% | 13,746 | -63.9% | 0.00% | 0.0% |
| Q1 2020 | $1,753,000 | +34.4% | 38,097 | +75.5% | 0.00% | 0.0% |
| Q4 2019 | $1,304,000 | -35.2% | 21,704 | -38.9% | 0.00% | 0.0% |
| Q3 2019 | $2,012,000 | +17.5% | 35,550 | +15.5% | 0.00% | 0.0% |
| Q2 2019 | $1,713,000 | +24.9% | 30,769 | +13.3% | 0.00% | 0.0% |
| Q1 2019 | $1,372,000 | +61.0% | 27,161 | +28.5% | 0.00% | 0.0% |
| Q4 2018 | $852,000 | -68.1% | 21,139 | -45.1% | 0.00% | 0.0% |
| Q3 2018 | $2,668,000 | +226.6% | 38,490 | +256.8% | 0.00% | 0.0% |
| Q2 2018 | $817,000 | +243.3% | 10,788 | +137.3% | 0.00% | – |
| Q1 2018 | $238,000 | -75.6% | 4,546 | -75.1% | 0.00% | -100.0% |
| Q4 2017 | $976,000 | +1526.7% | 18,283 | +1715.6% | 0.00% | – |
| Q3 2017 | $60,000 | -97.4% | 1,007 | -96.6% | 0.00% | -100.0% |
| Q2 2017 | $2,325,000 | -37.0% | 29,469 | -33.8% | 0.00% | -50.0% |
| Q1 2017 | $3,690,000 | -74.1% | 44,493 | -75.3% | 0.00% | -75.0% |
| Q4 2016 | $14,268,000 | +215.2% | 179,839 | +178.1% | 0.02% | +220.0% |
| Q3 2016 | $4,527,000 | -7.6% | 64,665 | -48.8% | 0.01% | -16.7% |
| Q2 2016 | $4,902,000 | +5060.0% | 126,375 | +5221.1% | 0.01% | – |
| Q1 2016 | $95,000 | -60.1% | 2,375 | -12.4% | 0.00% | – |
| Q4 2015 | $238,000 | +1152.6% | 2,712 | +943.1% | 0.00% | – |
| Q3 2015 | $19,000 | +46.2% | 260 | +58.5% | 0.00% | – |
| Q2 2015 | $13,000 | -98.4% | 164 | -99.2% | 0.00% | -100.0% |
| Q1 2015 | $820,000 | +81900.0% | 20,000 | +47519.0% | 0.00% | – |
| Q3 2014 | $1,000 | -99.2% | 42 | -99.5% | 0.00% | – |
| Q2 2014 | $128,000 | +12700.0% | 9,173 | +9980.2% | 0.00% | – |
| Q1 2014 | $1,000 | – | 91 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |